{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T14:16:20Z","timestamp":1789913780451,"version":"4.0.1"},"reference-count":30,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Medical Research and Opinion"],"published-print":{"date-parts":[[2006,2]]},"DOI":"10.1185\/030079906x89775","type":"journal-article","created":{"date-parts":[[2006,1,18]],"date-time":"2006-01-18T16:48:40Z","timestamp":1137602920000},"page":"397-404","source":"Crossref","is-referenced-by-count":42,"title":["Ocular permeation and inhibition of retinal inflammation: an examination of data and expert opinion on the clinical utility of nepafenac"],"prefix":"10.1185","volume":"22","author":[{"given":"Richard","family":"Lindstrom","sequence":"first","affiliation":[{"name":"Minnesota Eye Consultants, Minneapolis, MN, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry","family":"Kim","sequence":"additional","affiliation":[{"name":"Duke University Eye Center, Durham, North Carolina, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2006,1,17]]},"reference":[{"key":"e_1_2_1_2_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004397-200201000-00003"},{"key":"e_1_2_1_3_1","doi-asserted-by":"publisher","DOI":"10.1097\/00004397-199603610-00019"},{"key":"e_1_2_1_4_1","unstructured":"Lane SS Modi SS Holland EJ et al. Nepafenac ophthalmic suspension 0.1% before and after surgery for postoperative anterior segment inflammation. Paper presented at: American Society of Cataract and Refractive Surgery April 18 2005 Washington DC"},{"key":"e_1_2_1_5_1","unstructured":"Stewart WC Stewart R Maxwell WA et al. Preoperative and postoperative clinical evaluation of nepafenac 0.1% ophthalmic suspension for postcataract inflammation. Paper presented at: American Society of Cataract and Refractive Surgery April 18 2005 Washington DC"},{"key":"e_1_2_1_6_1","unstructured":"Donnenfeld ED Holland EJ Stewart R et al. Topical xibrom 0.1% investigational NSAID to decrease inflammation after cataract surgery. Paper presented at: American Society of Cataract and Refractive Surgery April 18 2005 Washington DC"},{"key":"e_1_2_1_7_1","doi-asserted-by":"crossref","unstructured":"Heier J Cheetham JK Degryse R et al. Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized vehicle-controlled clinical trial. Am J Ophthalmol 1999;127: 253\u20139","DOI":"10.1016\/S0002-9394(98)00413-9"},{"key":"e_1_2_1_8_1","first-page":"472","article-title":"Radial Keratotomy Study Group","volume":"125","author":"Yee RW","year":"1998","unstructured":"Yee RW, Ketorolac Radial Keratotomy Study Group. Analgesic efficacy and safety of nonpreserved ketorolac ophthalmic solution following radial keratotomy. Am J Ophthalmol 1998;125:472\u201380","journal-title":"Analgesic efficacy and safety of nonpreserved ketorolac ophthalmic solution following radial keratotomy. Am J Ophthalmol"},{"key":"e_1_2_1_9_1","first-page":"1022","article-title":"Sher NA","volume":"111","author":"Eiferman RA","year":"1993","unstructured":"Eiferman RA, Hoffman RS, Sher NA. Topical diclofenac reduced pain following photorefractive keratectomy. Arch Ophthalmol 1993;111:1022","journal-title":"Topical diclofenac reduced pain following photorefractive keratectomy. Arch Ophthalmol"},{"key":"e_1_2_1_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(14)72954-X"},{"key":"e_1_2_1_11_1","first-page":"2015","article-title":"Efficacy of topical ketorolac tromethamine 0","volume":"20","author":"Price MO","year":"2004","unstructured":"Price MO, Price FW. Efficacy of topical ketorolac tromethamine 0.4% for control of pain or discomfort associated with cataract surgery. Curr Med Res Opin 2004;20:2015\u20139","journal-title":"4% for control of pain or discomfort associated with cataract surgery. Curr Med Res Opin"},{"key":"e_1_2_1_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(82)34699-0"},{"key":"e_1_2_1_13_1","first-page":"357","article-title":"Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: I","volume":"24","author":"Gamache DA","year":"2000","unstructured":"Gamache DA, Graff G, Brady MT, et al. Nepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: I. Assessment of anti- inflammatory efficacy. Inflammation 2000;24:357\u201370","journal-title":"Assessment of anti- inflammatory efficacy. Inflammation"},{"key":"e_1_2_1_14_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1007001131987"},{"key":"e_1_2_1_15_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1026024409826"},{"key":"e_1_2_1_16_1","doi-asserted-by":"publisher","DOI":"10.1185\/030079905X50651"},{"key":"e_1_2_1_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-5155(99)00176-8"},{"key":"e_1_2_1_18_1","doi-asserted-by":"publisher","DOI":"10.1159\/000081203"},{"key":"e_1_2_1_19_1","first-page":"S289","article-title":"Efficacy of topical Voltaren in reducing the incidence of post operative cystoid macular edema","volume":"40","author":"McColgin AZ","year":"1999","unstructured":"McColgin AZ, Raizman MB. Efficacy of topical Voltaren in reducing the incidence of post operative cystoid macular edema. Invest Ophthmol Vis Sci 1999;40:S289","journal-title":"Invest Ophthmol Vis Sci"},{"key":"e_1_2_1_20_1","doi-asserted-by":"crossref","unstructured":"Sivaprasad S Bunce C Patel N. Non-steroidal anti-inflammatory agents for treating cystoid macular oedema following cataract surgery. Cochrane Database Syst Rev 2005;1:CD004239","DOI":"10.1002\/14651858.CD004239.pub2"},{"key":"e_1_2_1_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0886-3350(13)80484-1"},{"key":"e_1_2_1_22_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0886-3350(13)80485-3"},{"key":"e_1_2_1_23_1","first-page":"324","article-title":"Miura H","volume":"64","author":"Miyake K","year":"1980","unstructured":"Miyake K, Sakamura S, Miura H. Long-term follow-up study on prevention of aphakic cystoid macular oedema by topical indomethacin. Brit J Ophthalmol 1980;64:324\u20138","journal-title":"Long-term follow-up study on prevention of aphakic cystoid macular oedema by topical indomethacin. Brit J Ophthalmol"},{"key":"e_1_2_1_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(90)32423-5"},{"key":"e_1_2_1_25_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.72.12.4863"},{"key":"e_1_2_1_26_1","first-page":"582","article-title":"Reese DL","volume":"21","author":"Walsh DA","year":"1978","unstructured":"Walsh DA, Sancilio LF, Reese DL. Aroyl- and arylisoquinoline- acetic acids as antiinflammatory agents. J Med Chem 1978;21:582\u20135","journal-title":"Aroyl- and arylisoquinoline- acetic acids as antiinflammatory agents. J Med Chem"},{"key":"e_1_2_1_27_1","doi-asserted-by":"crossref","unstructured":"Walsh DA Moran HW Shamblee DA et al. Anti-inflammatory agents. 3. Synthesis and pharmacological evaluation of 2-amino- 3-benzoylphenylacetic acid and analogues. J Med Chem 1984;27: 1379\u201388","DOI":"10.1021\/jm00377a001"},{"key":"e_1_2_1_28_1","doi-asserted-by":"crossref","unstructured":"Walsh DA Moran HW Shamblee DA et al. Anti-inflammatory agents. 4. Syntheses and biological evaluation of potential prodrugs of 2-amino-3-benzoylbenzeneacetic acid and 2-amino-3-(4-chloro-benzoyl) benzeneacetic acid. J Med Chem 1990;33: 2296\u2013304","DOI":"10.1021\/jm00170a039"},{"key":"e_1_2_1_29_1","doi-asserted-by":"publisher","DOI":"10.1089\/jop.1991.7.227"},{"key":"e_1_2_1_30_1","first-page":"229","article-title":"Inhibitors of the arachidonic acid cascade in the management of ocular inflammation","volume":"312","author":"Srinivasan BD","year":"1989","unstructured":"Srinivasan BD, Kulkarni PS. Inhibitors of the arachidonic acid cascade in the management of ocular inflammation. Prog Clin Biol Res 1989;312:229\u201349","journal-title":"Prog Clin Biol Res"},{"key":"e_1_2_1_31_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.24.11693"}],"container-title":["Current Medical Research and Opinion"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1185\/030079906X89775","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T16:51:46Z","timestamp":1772729506000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1185\/030079906X89775"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,1,17]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2006,2]]}},"alternative-id":["10.1185\/030079906X89775"],"URL":"https:\/\/doi.org\/10.1185\/030079906x89775","relation":{},"ISSN":["0300-7995","1473-4877"],"issn-type":[{"value":"0300-7995","type":"print"},{"value":"1473-4877","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,1,17]]}}}